Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-048599
Filing Date
2021-12-16
Accepted
2021-12-16 16:05:23
Documents
1
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3731
  Complete submission text file 0000899243-21-048599.txt   5081
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address
Nader Francois (Reporting) CIK: 0001365343 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40384 | Film No.: 211497840

Mailing Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202
Business Address 201 E. JEFFERSON ST., SUITE 110B LOUISVILLE KY 40202 502-569-1059
Talaris Therapeutics, Inc. (Issuer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)